OA12074A - Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis. - Google Patents

Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis. Download PDF

Info

Publication number
OA12074A
OA12074A OA1200200121A OA1200200121A OA12074A OA 12074 A OA12074 A OA 12074A OA 1200200121 A OA1200200121 A OA 1200200121A OA 1200200121 A OA1200200121 A OA 1200200121A OA 12074 A OA12074 A OA 12074A
Authority
OA
OAPI
Prior art keywords
ncc
lactic acid
giardia intestinalis
prophylaxis
adhesion
Prior art date
Application number
OA1200200121A
Other languages
English (en)
Inventor
Eduardo Chiffrin
Pablo Perez
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of OA12074A publication Critical patent/OA12074A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
OA1200200121A 1999-10-26 2000-10-13 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis. OA12074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99121356 1999-10-26

Publications (1)

Publication Number Publication Date
OA12074A true OA12074A (en) 2006-05-04

Family

ID=8239282

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200121A OA12074A (en) 1999-10-26 2000-10-13 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.

Country Status (19)

Country Link
US (2) US6905679B1 (de)
EP (1) EP1227827B1 (de)
CN (1) CN1281220C (de)
AP (1) AP1563A (de)
AR (1) AR026248A1 (de)
AT (1) ATE290393T1 (de)
AU (1) AU1025001A (de)
BR (1) BR0015102B1 (de)
CA (1) CA2388952C (de)
CO (1) CO5280049A1 (de)
DE (1) DE60018591T2 (de)
DK (1) DK1227827T3 (de)
ES (1) ES2239622T3 (de)
MX (1) MXPA02004115A (de)
OA (1) OA12074A (de)
PE (1) PE20010676A1 (de)
PT (1) PT1227827E (de)
WO (1) WO2001030365A1 (de)
ZA (1) ZA200203008B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030365A1 (en) 1999-10-26 2001-05-03 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
EP2124966B1 (de) 2007-02-01 2015-09-09 IAMS Europe B.V. Verfahren zur verringerung von entzündung und oxidativem stress bei einem säugetier mit glucose-antimetaboliten, avocado oder avocado-extrakten
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーLa1NCC533(CNCMI−1225)及び免疫障害
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3011966A1 (de) 2014-08-08 2016-04-27 Institut National De La Recherche Agronomique Zusammensetzungen zur Hemmung von Giardia Lamblia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172245T1 (de) * 1992-07-06 1998-10-15 Nestle Sa Milchbakterien
SE9501056D0 (sv) 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
DK1048215T3 (da) * 1999-04-30 2004-11-29 Nestle Sa Forstærket vækst af mælkesyrebakterier i mælk
WO2001030365A1 (en) 1999-10-26 2001-05-03 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis

Also Published As

Publication number Publication date
MXPA02004115A (es) 2002-10-17
CA2388952C (en) 2008-06-10
EP1227827B1 (de) 2005-03-09
ATE290393T1 (de) 2005-03-15
CO5280049A1 (es) 2003-05-30
PT1227827E (pt) 2005-07-29
CA2388952A1 (en) 2001-05-03
BR0015102B1 (pt) 2014-03-18
AU1025001A (en) 2001-05-08
BR0015102A (pt) 2002-07-16
US20050186191A1 (en) 2005-08-25
CN1382056A (zh) 2002-11-27
EP1227827A1 (de) 2002-08-07
AR026248A1 (es) 2003-02-05
ES2239622T3 (es) 2005-10-01
WO2001030365A1 (en) 2001-05-03
AP1563A (en) 2006-02-02
US7229616B2 (en) 2007-06-12
AP2002002483A0 (en) 2002-06-30
DE60018591T2 (de) 2006-04-13
CN1281220C (zh) 2006-10-25
DE60018591D1 (de) 2005-04-14
US6905679B1 (en) 2005-06-14
ZA200203008B (en) 2003-09-23
DK1227827T3 (da) 2005-07-11
PE20010676A1 (es) 2001-07-11

Similar Documents

Publication Publication Date Title
EP0768375B2 (de) Milchbakterien
Fuller Probiotics 2: applications and practical aspects
US20200009202A1 (en) Bacterial composition and its use
US20040110270A1 (en) Bacterial composition and its use
US6926891B1 (en) Treatment of diarrhea with strains of Bifidobacterium longum
CN114774313B (zh) 鼠李糖乳杆菌LRa05在制备缓解便秘制品或调解肠道菌群制品方面的用途
CA2639961A1 (en) New lactobacillus strains and the uses thereof
US11376289B2 (en) Composition and uses thereof
US6905679B1 (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
CN117917475A (zh) 一种调节肠道菌群的植物乳植杆菌p16及其应用、产品和方法
AU2005232497A1 (en) Preventive and/or therapeutic agent for inflammatory bowel diseases
US20070134220A1 (en) Lactobacillus fermentum strain and uses thereof
RU2264450C2 (ru) Биопрепарат "бифистим для взрослых" для профилактики и лечения дисбактериозов и инфекционных болезней желудочно-кишечного тракта у людей старше 12 лет, биологически активная добавка к пище " бифистим для взрослых" для профилактики дисбактериозов и восстановления микрофлоры желудочно-кишечного тракта после антибиотикотерапии и других неблагоприятных воздействий у людей старше 12 лет и консорциум бифидобактерий для коррекции микрофлоры желудочно-кишечного тракта у людей старше 12 лет
JP6675703B1 (ja) 乳酸菌、該乳酸菌由来の自然免疫活性化剤、感染症予防・治療薬及び飲食品
KR100280366B1 (ko) 리팜피신과 각종 항생제에 내성을 갖는 신규 변이주인 엔테로코
Lee et al. The Effects of Kefir on MA-104 Cells Infected with Human Rotavirus and Diabetic Mouse; Review
Singh et al. PROBIOTICS IN MANAGEMENT OF DIABETES MELLITUS: PRESENT STATUS AND FUTURE PROSPECTS